Pharmacy Benefit Management Institute (PBMI) helps industry professionals manage pharmacy benefit programs through research-based drug benefit education.

Wednesday, April 26, 2006
Time	Activity	Speaker(s)
Noon to 1 pm	Registration
Prescription Drug Benefit Plan Design & Management Workshop
1 pm to 2:30 pm	Part I: Essentials of Benefit Design and Drug Mix Management Patient incentives and clinical strategies are an important part of effective drug benefit plan design and administration. Understand how deploying the industry's best clinical practices help plan sponsors manage drug mix and utilization translate to managing the rate of increase in drug expenditures.	Kimberly McDonough, PharmD President Advanced Pharmacy Concepts
2:30 pm to 2:45 pm	Break
2:45 pm to 4:15 pm	Part II: PBM Contracting Researching and contracting with a pharmacy benefit manager is the first, and, often, most difficult step to delivering a cost-effective drug benefit program. Identify the crucial contacting elements, pricing models, and performance guarantees instrumental in successfully contracting with a PBM. Explore case studies of effective employer-PBM contracting arrangements.	Tim Watson, PharmD, MBA Principal Pharmaceutical Strategies Group
4:15 pm to 4:30 pm	Break	Convention Foyer
4:30 pm to 5 pm	Hot Topics Discussion	Faculty

Thursday, April 27, 2006
7 am to 8 am	Registration	Registration Desk in Convention Foyer
7 am to 8 am	Continental Breakfast	Convention Foyer
8 am to 8:15 am	General Session Opening	Grande Ballroom CD
8:15 am to 9 am	PBM Marketplace Trends & Drug Management Issues Pharmacy benefit managers wrestle with many economic and clinical challenges on behalf of their plan sponsor customers. Learn about market trends that are causing prescription drug expenditures to increase. Explore market opportunities that may slow the rate of increase in drug prices and utilization.	Jerry Shipkin, RPh Vice President, Clinical Services Caremark
9 am to 9:45 am	Case Study: Documenting the Value of Prescription Compliance People with chronic conditions need to manage their conditions or the risk of serious complications which may result in emergency room visits and/or in-patient stays. Learn how one company identified members who were not taking their medications according to nationally accepted clinical guidelines and were then able to achieve outstanding clinical outcomes such as a 50% reduction in asthma-related emergency room and in-patient hospital visits. Understand how integrating medical, drug, and lab data helps to quantify value of compliance programs.	Thomas Stambaugh, RPh, MBA Chief Pharmacy Officer, VP Clinical Programs CIGNA Pharmacy Management
9:45 am to 10 am	Break	Grande Ballroom E, Convention Foyer
10 am to 10:45 am	Economics of Specialty Pharmacy Benefit Increasing numbers of injectable and biotech drugs for increasingly commonplace conditions and ailments make mastering the complexities of specialty pharmacy an imperative. Understanding the cost drivers of the specialty pharmacy benefit is critical to implementing a benefit design approach that minimizes employer liability and maximizes employee productivity. Explore case studies of effective specialty pharmacy benefit programs.	Randy Vogenberg, RPh, PhD Senior Vice President, National Practice Council Leader Aon Consulting
10:45 am to 11:30 am	The State of Oregon's Formulary Design Project The State of Oregon's Practitioner-Managed Prescription Drug Program is recognized as a cutting edge formulary driven by evidence-based formulary. Learn how this cutting-edge program reviews therapeutic classes and individual drug agents. Understand how Oregon provides incentives to reward health plan members' efforts to manage their own health.	Diane Lovell, Vice Chair Public Employees' Benefit Board State of Oregon
11:30 am to Noon	PBMI Rx Benefit Innovation Awards Ceremony	Grande Ballroom E
Noon	Awards Luncheon	Terraza

Thursday Afternoon Breakout Sessions, April 27, 2006
	Topic Group A Grande Ballroom C	Topic Group B Grande Ballroom D
1:30 pm to 2:15 pm	Utilization Management Strategies for High Growth Drug Classes Kevin Hooks, RPh President Catalyst Rx Direct-to-consumer advertising and other marketplace trends are fueling the growth of drug expenditures for sleep aid, bladder control, and pain medications. Effective use of copayment strategies, formulary tier placement, system edits, and generic dispensing can help control utilization. Using the sleep aids class as the case study example, explore how managing utilization curbs class expenditures.	Coordination of Benefits at Point of Sale Ed Borovatz, Vice President of Pharmacy First Health Services Corp. The plethora of Medicare Part D options and players make coordination of benefits an increasingly important aspect of retiree benefit management. Hear how coordination of benefits at the point of sale facilitates benefit management for both plan sponsor and plan participant. Understand audit approaches required to ensure benefit plan designs are implemented correctly.
2:15 pm to 3 pm	Examining the Promise of Electronic Prescribing Beth Bridges, RPh Vice President, Managed Care Solutions Allscripts It's intuitive that electronic prescribing improves patient safety by reducing medication errors. Learn about regional initiatives to increase electronic prescribing and document both the clinical and economic advantages for plan sponsors and their plan members.	Managing Maintenance Medication Case Study: Retail, Mail, 90-day at Retail and Other Strategies Bill Barre Vice President of Strategic Network Development MedImpact Maintenance medications are a critical aspect of all drug benefit programs. Both retail and mail-order pharmacies can effectively be used to dispense maintenance medications. Hear more about using the retail pharmacy for a maintenance medication strategy.
3:15 pm to 3:30 pm	Break Grande Ballroom E, Convention Foyer
3:30 pm to 4:15 pm	Disease Management Strategies for Specialty Pharmacy Michael Ziglinski, RPh, Vice President of Pharmacy John R. Zevzavadjian, RPh Vice President, Account Management PharmaCare Disease management strategies are critical for an effective specialty pharmacy benefit. Identify disease-specific management opportunities diseases such as hepatitis C and multiple sclerosis.	In-house Pharmacy Case Study J. Phil Belcher, Manager Health and Pharmacy Plans Eastman Chemical Company Frank A. Martin, Chairman CHD Meridian Healthcare Employers with worksite pharmacies often have the advantage of paying for their employees' prescriptions at the drug acquisition cost plus the cost of dispensing the prescription. Discuss the advantages of a worksite pharmacy, understanding how to conduct the analysis to determine if this strategy is a viable option for your company. Understand how the worksite pharmacy may offer added opportunities for managing utilization patterns.
4:15 pm to 5 pm	Managing Physician Prescribing Patterns Matthew Connell Vice President of Pharmacy BlueCross BlueShield of Massachusetts Providing physician incentives can be an effective strategy for increasing generic dispensing and formulary compliance to improve patient care and reduce drug expenditures. Discuss ways to measure physician performance and to structure incentives to measurably improve physician prescribing patterns.	Blockbuster Opportunities for Generic Drug Savings Piao Ching, RPh, MBA Pharmacy Manager Premera Blue Cross Many blockbuster drugs including Ambien® and Zocor® will be going off patent in 2006 with more to follow in the next few years. After estimating the potential savings of using generics for these costly brand-name drugs, discuss formulary management strategies to benefit from generic savings in a timely manner.
5 pm to 7 pm	PBMI Reception	Poolside

Friday, April 28, 2006
7:30 am to 8:30 am	PBM Advisory Council Breakfast	JD's Terrace
7:45 am to 8:30 am	Continental Breakfast	Convention Foyer
8:30 am to 9:15 am	Emerging PBM Transparency Standards The HR Policy Association's Pharmaceutical Purchasing Coalition of 52 large U.S. employers has moved the debate on transparency to the next level by certifying pharmacy benefit managers who meet their Transparency in Pharmaceutical Purchasing Solutions (TIPPS) standards. Learn more about these new PBM standards. Understand how increased disclosure of drug costs and pricing practices impacts benefit costs and use of cost-effective therapies.	Marisa Milton HR Policy Association Pharmaceutical Purchasing Coalition
9:15 am to 10 am	Update on Medicare Part D Implementation Medicare Part D drug coverage went live on 1/1/2006. Hundreds of employers are now working with CMS to provide retiree drug benefits. Assess progress made in the marketplace to date on Part D benefits and the implications of 2007 employer options.	Brenda Tranchida, Deputy Director Employer Policy & Operations Group Centers for Medicare & Medicaid Services
10 am to 10:15	Break	Grande Ballroom E, Convention Foyer
10:15 am to 11 am	Employer Decision-making Processes for 2007 Medicare Part D Options The majority of employers offering retiree drug coverage selected the subsidy option for 2006. It's now time to assess 2007 options for economic advantage and administrative ease. Understand the decision-making processes and resources necessary to make thoughtful decisions about selecting the best option for retiree coverage.	Dan Moriarty Director, Cost Containment Peabody Energy
11 am to 11:30 am	Joint Question-and-Answer Session on Medicare Part D	Faculty